Erik Ingelsson ASO
Автор: Front Line Genomics
Загружено: 2022-10-07
Просмотров: 203
Erik Ingelsson is Senior Vice President of Genomic Sciences at GSK. His teams use a range of genomics techniques in drug discovery, from computational biology to bulk sequencing approaches. Erik discusses the challenges of identifying drug candidates, ensuring diversity in the field and the benefits of a genetics first approach in drug discovery.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: